Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy.

@article{Steinle2012OralRU,
  title={Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy.},
  author={Nathan C. Steinle and Naina Gupta and Alex Yuan and Rishi Singh},
  journal={The British journal of ophthalmology},
  year={2012},
  volume={96 1},
  pages={10-3}
}
Chronic central serous retinopathy (CSR) is characterised by frequent exacerbations and a poor visual prognosis. Very few therapies exist for chronic CSR, and the existing therapies are often ineffective. Thus, novel therapies to combat this frustrating disorder are needed. Presented here is a case detailing a patient with chronic CSR with persistent subfoveal fluid of 2 years' duration that completely resolved with 1 month of oral rifampin therapy. As a cytochrome P450, 3A4 inducer, rifampin… CONTINUE READING

From This Paper

Topics from this paper.
15 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…